SLSBio(Specialty Lab Solution Bio) Co., Ltd Logo

SLSBio(Specialty Lab Solution Bio) Co., Ltd

Provides pharma lab services, clinical trial analysis, and innovative diagnostic products.

246250 | KO

Overview

Corporate Details

ISIN(s):
KR7246250005
LEI:
Country:
South Korea
Address:
경기도 수원시 영통구 창룡대로 260, 광교센트럴비즈타워7층 (이의동), 수원시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

SLSBio (Specialty Lab Solution Bio) Co., Ltd. is a life sciences company that provides a range of specialized services to the pharmaceutical and healthcare industries. The company's core offerings include pharmaceutical quality control, clinical trial sample analysis, bioequivalence testing, and new drug development support. In addition to its contract research services, SLSBio develops diagnostic technologies and test kits, leveraging its proprietary 'NTMD-Technology' platform to create innovative diagnostic products. The company's mission is to contribute to the enhancement of human health through its advanced laboratory solutions and dedicated research.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-08 00:00
Delisting Announcement
기타시장안내 (기업심사위원회 개최 결과 안내)
Korean 3.3 KB
2025-09-08 00:00
Delisting Announcement
주권매매거래정지기간변경 (상장폐지 사유 발생)
Korean 4.9 KB
2025-09-04 00:00
Legal Proceedings Report
[기재정정]주요사항보고서(영업정지)
Korean 12.3 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 697.3 KB
2025-08-11 00:00
Delisting Announcement
기타시장안내 (개선계획서 제출)
Korean 4.1 KB
2025-08-04 00:00
M&A Activity
[기재정정]주요사항보고서(유형자산양수결정)
Korean 22.3 KB
2025-07-21 00:00
Delisting Announcement
기타시장안내 (상장적격성 실질심사 대상 결정)
Korean 4.9 KB
2025-07-21 00:00
Delisting Announcement
주권매매거래정지기간변경 (상장적격성 실질심사 대상 결정)
Korean 4.7 KB
2025-06-30 00:00
Regulatory News Service
기타시장안내 (실질심사 대상여부 결정을 위한 조사기간 연장 안내)
Korean 3.3 KB
2025-06-30 00:00
Legal Proceedings Report
[기재정정]주요사항보고서(영업정지)
Korean 12.7 KB
2025-06-11 00:00
Legal Proceedings Report
[기재정정]주요사항보고서(영업정지)
Korean 13.9 KB
2025-06-10 00:00
Legal Proceedings Report
주요사항보고서(영업정지)
Korean 9.3 KB
2025-06-10 00:00
Regulatory News Service
기타시장안내 (상장적격성 실질심사 대상결정 기한 안내)
Korean 3.0 KB
2025-06-09 00:00
Delisting Announcement
기타시장안내 (상장적격성 실질심사 관련 안내)
Korean 2.8 KB
2025-06-09 00:00
Delisting Announcement
주권매매거래정지 (상장적격성 실질심사 대상 (사유발생))
Korean 4.6 KB

Automate Your Workflow. Get a real-time feed of all SLSBio(Specialty Lab Solution Bio) Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SLSBio(Specialty Lab Solution Bio) Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SLSBio(Specialty Lab Solution Bio) Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

FunPep Company Limited Logo
Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.
Japan
4881
Gain Therapeutics, Inc. Logo
Using an AI platform to develop allosteric therapies for neurodegenerative diseases.
United States of America
GANX
Galaxy Payroll Group Ltd Logo
APAC cross-border payroll, EOR, and corporate services for global businesses.
United States of America
GLXG
GATX CORP Logo
Global lessor of railcars, locomotives, and spare aircraft engines for key industries.
United States of America
GATX
GECOSS CORPORATION Logo
Leases and sells temporary steel materials and equipment for large construction projects.
Japan
9991
GENDAI AGENCY INC. Logo
Advertising agency providing marketing and promotions for the pachinko industry.
Japan
2411
Geneuro Logo
Developing antibody therapies targeting pathogenic HERVs for MS and post-COVID syndromes.
Switzerland
GEM
Developing long-acting immunotherapeutics for immuno-oncology and rare diseases.
South Korea
095700
GENFLOW BIOSCIENCES PLC Logo
Develops gene therapies to slow aging and treat age-related diseases in humans and dogs.
United Kingdom
GENF
GENINUS Inc. Logo
AI-powered genomic and multi-omics analysis for precision medicine and clinical partners.
South Korea
389030

Talk to a Data Expert

Have a question? We'll get back to you promptly.